Diabetes Care

• 

  Publication Venue For

  • Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report..  42:731-754. 2019
  • Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL). 2019
  • Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study..  42:486-493. 2019
  • Reduction of Cardiovascular Risk and Improved Estimated Glomerular Filtration Rate by SGLT2 Inhibitors, Including Dapagliflozin, Is Consistent Across the Class: An Analysis of the Placebo Arm of EXSCEL..  42:318-326. 2019
  • An Automated Grading System for Detection of Vision-Threatening Referable Diabetic Retinopathy on the Basis of Color Fundus Photographs..  41:2509-2516. 2018
  • Fasting Glucose Variability in Young Adulthood and Cognitive Function in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study..  41:2579-2585. 2018
  • Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)..  41:2669-2701. 2018
  • Baseline Characteristics of the Vitamin D and Type 2 Diabetes (D2d) Study: A Contemporary Prediabetes Cohort That Will Inform Diabetes Prevention Efforts..  41:1590-1599. 2018
  • Can We RISE to the Challenge of Youth-Onset Type 2 Diabetes?.  41:1560-1562. 2018
  • Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial..  41:1391-1399. 2018
  • Response to Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401-1408..  41:e90-e91. 2018
  • Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype..  41:596-603. 2018
  • Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum..  41:14-31. 2018
  • The Effect of Telemedicine Follow-up Care on Diabetes-Related Foot Ulcers: A Cluster-Randomized Controlled Noninferiority Trial..  41:96-103. 2018
  • Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial..  40:1763-1770. 2017
  • Metformin Use May Moderate the Effect of DPP-4 Inhibitors on Cardiovascular Outcomes..  40:1787-1789. 2017
  • What End Users and Stakeholders Want From Automated Insulin Delivery Systems..  40:1453-1461. 2017
  • Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. 2017
  • Maternal BMI and Glycemia Impact the Fetal Metabolome..  40:902-910. 2017
  • Targeted Metabolomics Demonstrates Distinct and Overlapping Maternal Metabolites Associated With BMI, Glucose, and Insulin Sensitivity During Pregnancy Across Four Ancestry Groups..  40:911-919. 2017
  • Sodium-Glucose Cotransporter 2 Inhibitors and Diabetic Ketoacidosis: A Case Series From Three Academic Institutions..  40:e65-e66. 2017
  • Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).  40:494-501. 2017
  • Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)..  40:494-501. 2017
  • Management of hemoglobin variants detected incidentally in HbA 1c testing: A common problem currently lacking a standard approach.  40:e8-e9. 2017
  • Pancreatic Safety of Sitagliptin in the TECOS Study..  40:164-170. 2017
  • Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial..  40:63-68. 2017
  • Diabetes care: "Taking it to the limit one more time".  40:3-6. 2017
  • Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS..  39:2304-2310. 2016
  • A Smartphone Application to Deliver a Treat-to-Target Insulin Titration Algorithm in Insulin-Naive Patients With Type 2 Diabetes: A Pilot Randomized Controlled Trial..  39:e174-e176. 2016
  • Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990 to 2010..  39:1643-1649. 2016
  • Diabetes care: Lagniappe and seeing is believing!.  39:1069-1071. 2016
  • Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia..  39:1230-1240. 2016
  • Bariatric Surgery: A Potential Treatment for Type 2 Diabetes in Youth..  39:934-940. 2016
  • Continuous Glucose Monitoring in the Self-management of Type 2 Diabetes: A Paradigm Shift..  39:e71-e73. 2016
  • Branched-Chain Amino Acids and Insulin Metabolism: The Insulin Resistance Atherosclerosis Study (IRAS)..  39:582-588. 2016
  • Diabetes and the Association of Postoperative Hyperglycemia With Clinical and Economic Outcomes in Cardiac Surgery..  39:408-417. 2016
  • Expanding Treatment Options for Youth With Type 2 Diabetes: Current Problems and Proposed Solutions.  39:323-329. 2016
  • Could the discrepancy in perceived emotional care received and provided be a barrier to active diabetes selfmanagement? Insights from the second diabetes attitudes, wishes and needs (DAWN2) study.  39:e20-e21. 2016
  • Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia..  39:300-307. 2016
  • Building Momentum: Taking on the Real “Issues” of Diabetes Care!.  39:10-12. 2016
  • Momentary Predictors of Insulin Restriction Among Adults With Type 1 Diabetes and Eating Disorder Symptomatology..  38:2025-2032. 2015
  • Erratum. Improving Diabetes Management and Cardiovascular Risk Factors Through Peer-Led Self-management Support Groups in Western Kenya. Diabetes Care 2015;38:e110–e111.  38:1993-1993. 2015
  • Clinical Utility of SMBG: Recommendations on the Use and Reporting of SMBG in Clinical Research..  38:1627-1633. 2015
  • Improving diabetes management and cardiovascular risk factors through peer-led self-management support groups in western Kenya.  38:e110-e111. 2015
  • Patient-reported outcomes and continuous glucose monitoring: Can we do better with artificial pancreas devices?.  38:e70. 2015
  • Response to comment on Tay et al. A very low-carbohydrate, low-saturated fat diet for type 2 diabetes management: a randomized trial. Diabetes Care 2014;37:2909-2918..  38:e65-e66. 2015
  • Trends in diabetes incidence: the Framingham Heart Study..  38:482-487. 2015
  • Rationale and design of the Vitamin D and Type 2 Diabetes (D2d) study: a diabetes prevention trial..  37:3227-3234. 2014
  • A very low-carbohydrate, low-saturated fat diet for type 2 diabetes management: a randomized trial..  37:2909-2918. 2014
  • Comment on Doyle et al. Closed-loop artificial pancreas systems: engineering the algorithms. Diabetes Care 2014;37:1191-1197..  37:e226-e227. 2014
  • Diabetic kidney disease: a report from an ADA Consensus Conference..  37:2864-2883. 2014
  • HARMONY 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metformin..  37:2141-2148. 2014
  • Response to comments on Evert et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes care 2013;36:3821-3842..  37:e102-e103. 2014
  • Ocular anti-VEGF therapy for diabetic retinopathy: overview of clinical efficacy and evolving applications..  37:900-905. 2014
  • Association of glomerular filtration rate with outcomes of acute stroke in type 2 diabetic patients: results from the China National Stroke Registry..  37:173-179. 2014
  • Metabolomics reveals broad-scale metabolic perturbations in hyperglycemic mothers during pregnancy..  37:158-166. 2014
  • Nutrition therapy recommendations for the management of adults with diabetes..  37 Suppl 1:S120-S143. 2014
  • Nutrition therapy recommendations for the management of adults with diabetes..  36:3821-3842. 2013
  • Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial..  36:3613-3619. 2013
  • Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review..  36:3337-3345. 2013
  • Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort..  36:3208-3215. 2013
  • Circulating estrone levels are associated prospectively with diabetes risk in men of the Framingham Heart Study..  36:2591-2596. 2013
  • Exercise training and quality of life in individuals with type 2 diabetes: a randomized controlled trial..  36:1884-1890. 2013
  • Associations between diabetes, leanness, and the risk of death in the Japanese general population: the Jichi Medical School Cohort Study..  36:1186-1192. 2013
  • Retinal vascular caliber as a biomarker for diabetes microvascular complications..  36:750-759. 2013
  • Determinants of weight gain in the action to control cardiovascular risk in diabetes trial.  36:2162-2168. 2013
  • Neck circumference and the development of cardiovascular disease risk factors in the Framingham Heart Study..  36:e3. 2013
  • Pharmacodynamic effect of cilostazol plus standard clopidogrel versus double-dose clopidogrel in patients with type 2 diabetes undergoing percutaneous coronary intervention..  35:2194-2197. 2012
  • Remogliflozin Etabonate, a Selective Inhibitor of the Sodium-Glucose Transporter 2, Improves Serum Glucose Profiles in Type 1 Diabetes.  35:2198-2200. 2012
  • Improvement in outcomes of clinical islet transplantation: 1999-2010..  35:1436-1445. 2012
  • Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial..  35:1525-1531. 2012
  • Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1C targets..  35:1446-1454. 2012
  • Association of high pulse pressure with proteinuria in subjects with diabetes, prediabetes, or normal glucose tolerance in a large Japanese general population sample..  35:1310-1315. 2012
  • Macronutrients, food groups, and eating patterns in the management of diabetes: A systematic review of the literature, 2010 (Diabetes Care (2012) 35, (434-445)).  35:1395. 2012
  • Response to comment on: Wheeler et al. Macronutrients, food groups, and eating patterns in the management of diabetes: A systematic review of the literature, 2010. Diabetes Care 2012;35:434-445.  35. 2012
  • Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease..  35:994-1001. 2012
  • Early retinal arteriolar changes and peripheral neuropathy in diabetes..  35:1098-1104. 2012
  • Global prevalence and major risk factors of diabetic retinopathy..  35:556-564. 2012
  • Retinal vascular geometry predicts incident renal dysfunction in young people with type 1 diabetes..  35:599-604. 2012
  • Macronutrients, food groups, and eating patterns in the management of diabetes: a systematic review of the literature, 2010..  35:434-445. 2012
  • The impact of frequent and unrecognized hypoglycemia on mortality in the ACCORD study..  35:409-414. 2012
  • Urinary F2-isoprostanes as a biomarker of reduced risk of type 2 diabetes..  35:173-174. 2012
  • Sex hormone-binding globulin, but not testosterone, is associated prospectively and independently with incident metabolic syndrome in men: the framingham heart study..  34:2464-2470. 2011
  • Erratum.  34:1888.2-1888. 2011
  • Retinal vascular geometry predicts incident retinopathy in young people with type 1 diabetes: a prospective cohort study from adolescence..  34:1622-1627. 2011
  • Diabetic retinopathy is related to both endothelium-dependent and -independent responses of skin microvascular flow..  34:1389-1393. 2011
  • Diabetic retinopathy in 2011: further insights from new epidemiological studies and clinical trials..  34:1066-1067. 2011
  • Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids..  34:474-479. 2011
  • The association between maternal glucose concentration and child BMI at age 3 years..  34:480-484. 2011
  • Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms..  34:121-125. 2011
  • Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes..  34:145-150. 2011
  • Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes..  33:2156-2163. 2010
  • Screening adults for pre-diabetes and diabetes may be cost-saving..  33:1484-1490. 2010
  • Alterations in retinal microvascular geometry in young type 1 diabetes..  33:1331-1336. 2010
  • Relationships between metabolic syndrome and other baseline factors and the efficacy of ezetimibe/simvastatin and atorvastatin in patients with type 2 diabetes and hypercholesterolemia..  33:1021-1024. 2010
  • History of foot ulcer increases mortality among individuals with diabetes: ten-year follow-up of the Nord-Trøndelag Health Study, Norway..  32:2193-2199. 2009
  • Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis..  32:2307-2313. 2009
  • Flicker light-induced retinal vasodilation in diabetes and diabetic retinopathy..  32:2075-2080. 2009
  • Effects of exercise training intensity on pancreatic beta-cell function..  32:1807-1811. 2009
  • Inflammatory, hemostatic, and other novel biomarkers for diabetic retinopathy: the multi-ethnic study of atherosclerosis..  32:1704-1709. 2009
  • Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women..  32:1678-1683. 2009
  • One-year comparison of a high-monounsaturated fat diet with a high-carbohydrate diet in type 2 diabetes..  32:215-220. 2009
  • Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program.  32:915-920. 2009
  • Quantitative assessment of early diabetic retinopathy using fractal analysis..  32:106-110. 2009
  • Ocular associations of diabetes other than diabetic retinopathy..  31:1905-1912. 2008
  • Retinal arteriolar dilation predicts retinopathy in adolescents with type 1 diabetes..  31:1842-1846. 2008
  • Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes (vol 30, pg 1979, 2007).  31:1713-1714. 2008
  • Erratum: For the Sitagliptin 036 Study Group: Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes (Diabetes Care (2007) 30 (1979-1987)).  31:1713. 2008
  • Health care use and costs associated with use of a health club membership benefit in older adults with diabetes..  31:1562-1567. 2008
  • Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham heart study..  31:1582-1584. 2008
  • Longitudinal association of glucose metabolism with retinopathy: results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study..  31:1349-1354. 2008
  • Influence of flickering light on the retinal vessels in diabetic patients: response to Mandecka et al..  31:e51. 2008
  • Metabolic phenotype in the brothers of women with polycystic ovary syndrome..  31:1237-1241. 2008
  • Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial..  31:1007-1014. 2008
  • Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study..  31:741-746. 2008
  • Retinal arteriolar caliber predicts incident retinopathy: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study..  31:761-763. 2008
  • Evidence of a relationship between infant birth weight and later diabetes and impaired glucose regulation in a Chinese population..  31:483-487. 2008
  • Relationship of retinal vascular caliber with diabetes and retinopathy: the Multi-Ethnic Study of Atherosclerosis (MESA)..  31:544-549. 2008
  • Accuracy of perceptions of overweight and relation to self-care behaviors among adolescents with type 2 diabetes and their parents..  31:227-229. 2008
  • Caffeine increases ambulatory glucose and postprandial responses in coffee drinkers with type 2 diabetes..  31:221-222. 2008
  • Resting heart rate in middle age and diabetes development in older age..  31:335-339. 2008
  • Costs of the metabolic syndrome in elderly individuals: findings from the Cardiovascular Health Study..  30:2553-2558. 2007
  • Erratum: Diabetic retinopathy and the risk of coronary heart disease: The Atherosclerosis Risk in Communities Study (Diabetes Care (2007) 30, (1742-1746)).  30:2762. 2007
  • Retinal vascular changes in pre-diabetes and prehypertension: new findings and their research and clinical implications..  30:2708-2715. 2007
  • Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study..  30:1742-1746. 2007
  • Characterizing young patients with diabetes and non-ST-segment elevation acute coronary syndromes..  30:731-733. 2007
  • Pharmacotherapy of childhood obesity: an evidence-based, conceptual approach..  30:395-402. 2007
  • Impact of a managed-Medicare physical activity benefit on health care utilization and costs in older adults with diabetes..  30:43-48. 2007
  • Continuous glucose monitoring-guided insulin adjustment in children and adolescents on near-physiological insulin regimens: a randomized controlled trial..  29:1512-1517. 2006
  • High-risk individuals' willingness to pay for diabetes risk-reduction programs..  29:1351-1356. 2006
  • Is peripheral neuropathy associated with retinopathy and albuminuria in individuals with impaired glucose metabolism? The 1999-2000 AusDiab..  29:1114-1116. 2006
  • Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression..  29:265-270. 2006
  • Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes..  29:9-14. 2006
  • Risking health to avoid injections: preferences of Canadians with type 2 diabetes..  28:2243-2245. 2005
  • Fiber and C-reactive protein in diabetes, hypertension, and obesity..  28:1487-1489. 2005
  • Early pregnancy insulin resistance and subsequent gestational diabetes mellitus..  28:1207-1208. 2005
  • Caffeine impairs glucose metabolism in type 2 diabetes..  27:2047-2048. 2004
  • Effectiveness of diabetic therapeutic footwear in preventing reulceration..  27:1774-1782. 2004
  • Diabetes-related utilization and costs for inpatient and outpatient services in the Veterans Administration..  27 Suppl 2:B69-B73. 2004
  • The effect of the PREMIER interventions on insulin sensitivity..  27:340-347. 2004
  • Inflammation and glucose intolerance: a prospective study of gestational diabetes mellitus..  27:21-27. 2004
  • Screening for celiac disease in children with type 1 diabetes: two views of the controversy..  26:1932-1939. 2003
  • Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans..  26:791-798. 2003
  • First-trimester C-reactive protein and subsequent gestational diabetes..  26:819-824. 2003
  • Prevalence and costs of major depression among elderly claimants with diabetes..  26:415-420. 2003
  • Quality of care for patients diagnosed with diabetes at screening..  26:367-371. 2003
  • Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III..  26:468-470. 2003
  • Weight control practices and disordered eating behaviors among adolescent females and males with type 1 diabetes: associations with sociodemographics, weight concerns, familial factors, and metabolic outcomes..  25:1289-1296. 2002
  • Impact of diabetes screening on quality of life..  25:1022-1026. 2002
  • Hostility, race, and glucose metabolism in nondiabetic individuals..  25:835-839. 2002
  • Stress management improves long-term glycemic control in type 2 diabetes..  25:30-34. 2002
  • Rate and predictors of glycemic testing of nondiabetic patients in a managed care population..  24:957-959. 2001
  • Behavioral science research in diabetes: lifestyle changes related to obesity, eating behavior, and physical activity..  24:117-123. 2001
  • Personality correlates of glycemic control in type 2 diabetes..  23:1321-1325. 2000
  • Novel hepatoselective insulin analog: studies with a covalently linked thyroxyl-insulin complex in humans.  23:1124-1129. 2000
  • Is there a glycemic threshold for impaired autonomic control?.  23:826-830. 2000
  • Glycemic control and impaired autonomic function: Is glucose the sole culprit? [11].  23:1863-1864. 2000
  • The family and disease management in hispanic and European-American patients with type 2 diabetes.  23:267-272. 2000
  • Determining an episode of care using claims data. Diabetic foot ulcer..  22:1110-1115. 1999
  • Oral agent therapy in the treatment of type 2 diabetes..  22 Suppl 3:C61-C64. 1999
  • Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study..  21:949-958. 1998
  • Prevalences of type 2 diabetes, the insulin resistance syndrome, and coronary heart disease in an elderly, biethnic population..  21:959-966. 1998
  • Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points..  21:655-657. 1998
  • Efficacy and safety of acarbose in metformin-treated patients with type 2 diabetes.  21:2050-2055. 1998
  • Physical activity and niddm in African-Americans: Pitt County study.  21:555-562. 1998
  • Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes..  20:1539-1542. 1997
  • Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group..  20:597-606. 1997
  • Solitary pancreas transplantation. Experience with 62 consecutive cases..  20:362-368. 1997
  • Major depressive disorder in youths with IDDM. A controlled prospective study of course and outcome..  20:45-51. 1997
  • Psychiatric disorders in youths with IDDM: rates and risk factors..  20:36-44. 1997
  • Clinical and radiographic findings that lead to intervention in diabetic patients with foot ulcers. A nationwide survey of primary care physicians..  19:755-757. 1996
  • Magnesium supplementation in the treatment of diabetes.  19. 1996
  • Magnesium supplementation in the treatment of diabetes.  18:83-85. 1995
  • Lipoprotein(a) and silent myocardial ischemia in IDDM..  17:1365-1367. 1994
  • A telephone-delivered intervention for patients with NIDDM. Effect on coronary risk factors..  17:840-846. 1994
  • Relaxation training for NIDDM. Predicting who may benefit..  16:1087-1094. 1993
  • Pancreas transplantation for patients with diabetes mellitus. American Diabetes Association..  15:1673. 1992
  • Pancreas transplantation for patients with diabetes mellitus. American Diabetes Association..  15:1668-1672. 1992
  • Screening for microalbuminuria. A comparison of single sample methods of collection and techniques of albumin analysis..  15:1581-1584. 1992
  • Stress and diabetes mellitus..  15:1413-1422. 1992
  • Magnesium supplementation in the treatment of diabetes. American Diabetes Association..  15:1065-1067. 1992
  • Do you really get a diet soft drink when you order one?.  15:933-934. 1992
  • Plasma levels of beta-endorphin and adrenocorticotropic hormone in IDDM and NIDDM..  15:590-591. 1992
  • Do you really get a diet soft drink when you order one? [3].  15:940-941. 1992
  • Impact of glucose self-monitoring on non-insulin-treated patients with type II diabetes mellitus. Randomized controlled trial comparing blood and urine testing..  13:1044-1050. 1990
  • Family functioning and metabolic control of school-aged children with IDDM..  12:409-414. 1989
  • Accuracy of nurses in performing capillary blood glucose monitoring..  12:298-301. 1989
  • Psychological predictors of glucose control in patients with IDDM..  11:798-800. 1988
  • Prevalence of asymptomatic bacteriuria in subjects with NIDDM in San Luis Valley of Colorado..  11:708-712. 1988
  • Type A behavior pattern and chronic glycemic control in individuals with IDDM..  11:361-362. 1988
  • Stress and autonomic nervous system in type II diabetes. A hypothesis..  11:83-85. 1988
  • Relaxation Therapy: A Reply.  10:794-795. 1987
  • Cognitive Functioning and Diabetes: A Reply.  10:136-137. 1987
  • Effects of relaxation therapy on patients with type I diabetes mellitus..  10:72-75. 1987
  • Differential glycemic response to stress in type A and type B individuals with IDDM..  9:550-552. 1986
  • Relaxation-induced improvement in glucose tolerance is associated with decreased plasma cortisol..  7:203-204. 1984
  • Accuracy of two systems for blood glucose monitoring without a meter (Chemstrip/Visidex)..  6:533-535. 1983
  • The effects of relaxations on glucose tolerance in non-insulin-dependent diabetes..  6:176-179. 1983
  • Porcine and human insulin (Novo): a comparison of their metabolism and hypoglycemic activity in normal man..  6 Suppl 1:9-12. 1983
  • Induced basal normoglycemia and altered platelet aggregation in non-insulin-dependent diabetes..  5:433-437. 1982
  • The role of behavior in diabetes care..  5:337-342. 1982
  • A double-blind crossover trial comparing human insulin (recombinant DNA) with animal insulins in the treatment of previously insulin-treated diabetic patients..  5 Suppl 2:129-134. 1982
  • Myocardial infarction site and mortality in diabetes..  5:31-35. 1982
  • An algebra for adiposity?.  4:328-329. 1981
  • FOR READING ON WRITING.  3:198-198. 1980
  • Immunologic reactions to insulin..  3:204. 1980
  • Sulfonylurea drugs: mechanism of antidiabetic action and therapeutic usefulness..  1:189-198. 1978
  • Effect of A1C and Glucose on Postoperative Mortality in Noncardiac and Cardiac Surgeries. 2018